OHE staff recently attended the European Health Economics Association (EuHEA) 2018 conference. In this blog post, we share a selection of our presentations. Establishing a Reasonable…
OHE staff recently attended the European Health Economics Association (EuHEA) 2018 conference. In this blog post, we share a selection of our presentations.
Establishing a Reasonable Price for an Orphan Drug from Office of Health Economics
R&D, Competition and Diffusion of Innovation in EU: The Case of Direct Acting Antivirals (DAAs) for Hepatitis C from Office of Health Economics
Key factors driving access and uptake of hepatitis C treatments in Europe. Results from experts interviews from Office of Health Economics
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public’s Preferences from Office of Health Economics
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Time? A Longitudinal Study of Cancer Patients from Office of Health Economics